GB0320793D0 - Chemical process - Google Patents

Chemical process

Info

Publication number
GB0320793D0
GB0320793D0 GB0320793A GB0320793A GB0320793D0 GB 0320793 D0 GB0320793 D0 GB 0320793D0 GB 0320793 A GB0320793 A GB 0320793A GB 0320793 A GB0320793 A GB 0320793A GB 0320793 D0 GB0320793 D0 GB 0320793D0
Authority
GB
United Kingdom
Prior art keywords
chemical process
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0320793A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0320793A priority Critical patent/GB0320793D0/en
Publication of GB0320793D0 publication Critical patent/GB0320793D0/en
Priority to PCT/GB2004/003720 priority patent/WO2005023783A1/en
Ceased legal-status Critical Current

Links

GB0320793A 2003-09-05 2003-09-05 Chemical process Ceased GB0320793D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0320793A GB0320793D0 (en) 2003-09-05 2003-09-05 Chemical process
PCT/GB2004/003720 WO2005023783A1 (en) 2003-09-05 2004-09-01 Process for the manufacture of gefitinib

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0320793A GB0320793D0 (en) 2003-09-05 2003-09-05 Chemical process

Publications (1)

Publication Number Publication Date
GB0320793D0 true GB0320793D0 (en) 2003-10-08

Family

ID=29226532

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0320793A Ceased GB0320793D0 (en) 2003-09-05 2003-09-05 Chemical process

Country Status (2)

Country Link
GB (1) GB0320793D0 (en)
WO (1) WO2005023783A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1300118C (en) * 2005-08-25 2007-02-14 江苏吴中苏药医药开发有限责任公司 Preparation method of 4-(3-chlor-4-fluorobenzeneamidocyanogen)-7-methoxy-6-(3-morpholine oxypropyl)quinazoline
JP2010524909A (en) 2007-04-16 2010-07-22 シプラ・リミテッド Method for producing gefitinib
WO2010061400A1 (en) * 2008-11-03 2010-06-03 Natco Pharma Limited A novel process for the preparation of lapatinib and its pharmaceutically acceptable salts
BRPI1013854A2 (en) * 2009-04-23 2017-05-16 Astrazeneca Ab process for preparing compound, compound, and salt of a compound
CN102120731B (en) * 2010-01-09 2015-01-07 浙江华海药业股份有限公司 Novel method for preparing 4-(3-chlorine-4-fluorophenylamino)-7-methoxyl-6-(3-morpholinepropoxy)quinazoline
PT2729173T (en) 2011-07-06 2016-09-22 Sykehuset Sorlandet Hf Egfr targeted therapy
CN102659716B (en) * 2012-05-02 2014-09-10 北京国联诚辉医药技术有限公司 Method for preparing 4-methoxyl-2-amido-3-[3-(4-morpholino) oxypropyl]cyanophenyl and process for preparing gefitinib
KR101457453B1 (en) * 2012-05-31 2014-11-04 주식회사 종근당 Process for preparing gefitinib and an intermediate used for preparing thereof
CN103570633B (en) * 2012-07-27 2015-08-05 中国科学院广州生物医药与健康研究院 The preparation method of Gefitinib
JP2016507493A (en) 2012-12-21 2016-03-10 スィーケフス ソールラン ホーエフ EGFR targeted treatment of neuropathy and pain
CN103739558B (en) * 2013-09-23 2016-05-04 南京优科生物医药研究有限公司 A kind of preparation method of Gefitinib known impurities
CN105968103B (en) * 2016-07-18 2018-11-27 山东罗欣药业集团恒欣药业有限公司 The synthetic method of anti-tumor drug Afatinib
CN107698523A (en) * 2017-09-26 2018-02-16 盐城师范学院 A kind of preparation method of tyrosine kinase inhibitor Gefitinib
CN109384747A (en) * 2018-10-26 2019-02-26 苏州立新制药有限公司 Gefitinib related substances and its preparation and detection method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
US6384223B1 (en) * 1998-07-30 2002-05-07 American Home Products Corporation Substituted quinazoline derivatives
PL360439A1 (en) * 2000-06-28 2004-09-06 Astrazeneca Ab Substituted quinazoline derivatives and their use as inhibitors

Also Published As

Publication number Publication date
WO2005023783A1 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
GB0324791D0 (en) Chemical process
GB0312896D0 (en) Chemical process
TWI316058B (en) Chemical process
IL165286A0 (en) Chemical process
GB0306432D0 (en) Process
GB0303659D0 (en) Process
GB0320793D0 (en) Chemical process
GB0218041D0 (en) Chemical process
GB0307259D0 (en) Process
GB0229803D0 (en) Chemical process
GB0216412D0 (en) Chemical process
GB0210370D0 (en) Chemical process
GB0222833D0 (en) Chemical process
GB0313920D0 (en) Chemical process
GB0302648D0 (en) Chemical process
GB0308672D0 (en) Process
GB0300733D0 (en) Process
GB0313909D0 (en) Chemical process
GB0313908D0 (en) Chemical process
GB0313917D0 (en) Chemical process
GB0313911D0 (en) Chemical process
GB0320795D0 (en) Chemical process
GB0313919D0 (en) Chemical process
GB0313910D0 (en) Chemical process
GB0324545D0 (en) Chemical process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)